XML 66 R54.htm IDEA: XBRL DOCUMENT v3.25.1
Share-Based Compensation - Summary of the Option Unit Activity (Details)
$ / shares in Units, $ in Millions
 3 Months Ended
Mar. 31, 2025
USD ($)
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Weighted Average Remaining Contractual Term, Grants Vested 1 year 1 month 6 days
2021 Equity Plan [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of units, grant outstanding beginning balance | shares 4,517,897
Number of grants, exercised | shares (6,487)
Number of grants, issued | shares 553,266
Number of grants, cancelled/forfeited | shares (18,824)
Number of units, grant outstanding ending balance | shares 5,045,852
Number of grants, vested | shares 2,602,560
Number of grants, unvested | shares 2,443,292
Weighted average exercise price, grant outstanding beginning balance | $ / shares $ 14.38
Weighted average exercise price, grants exercised | $ / shares 13.93
Weighted average exercise price, grants issued | $ / shares 14.23
Weighted average exercise price, cancelled/forfeited | $ / shares 13.64
Weighted average exercise price, grant outstanding ending balance | $ / shares 14.37
Weighted average exercise price, grants vested | $ / shares 13.71
Weighted average exercise price, grants unvested | $ / shares $ 15.06
Weighted Average Remaining Contractual Term, Grants Outstanding 7 years 4 months 24 days
Weighted Average Remaining Contractual Term, Grants Vested 6 years 6 months
Aggregate Intrinsic Value, grants outstanding | $ $ 2.5
Aggregate Intrinsic Value, grants vested | $ $ 1.6
First Advantage Corporation [Member] | 2020 Equity Plan [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of units, grant outstanding beginning balance | shares 1,602,966
Number of grants, exercised | shares (145,483)
Number of grants, cancelled/forfeited | shares (29,074)
Number of units, grant outstanding ending balance | shares 1,428,409
Number of grants, vested | shares 1,009,021
Number of grants, unvested | shares 419,388
Weighted average exercise price, grant outstanding beginning balance | $ / shares $ 5.15
Weighted average exercise price, grants exercised | $ / shares 5.11
Weighted average exercise price, cancelled/forfeited | $ / shares 5.19
Weighted average exercise price, grant outstanding ending balance | $ / shares 5.15
Weighted average exercise price, grants vested | $ / shares 5.13
Weighted average exercise price, grants unvested | $ / shares $ 5.2
Weighted Average Remaining Contractual Term, Grants Outstanding 4 years 9 months 18 days
Weighted Average Remaining Contractual Term, Grants Vested 4 years 8 months 12 days
Aggregate Intrinsic Value, grants outstanding | $ $ 12.8
Aggregate Intrinsic Value, grants vested | $ $ 9.0